{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "58468-0080",
      "generic_name": "Anti-thymocyte Globulin (Rabbit)",
      "labeler_name": "Genzyme Corporation",
      "brand_name": "Thymoglobulin",
      "active_ingredients": [
        {
          "name": "LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN",
          "strength": "5 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "58468-0080-1",
          "description": "1 VIAL, GLASS in 1 CARTON (58468-0080-1)  / 5 mL in 1 VIAL, GLASS",
          "marketing_start_date": "19981230",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Genzyme Corporation"
        ],
        "rxcui": [
          "107047",
          "107050"
        ],
        "spl_set_id": [
          "bbd8ab99-552e-4b81-aca4-6b0c7af8b9ae"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000184163",
          "N0000178327",
          "N0000009689",
          "N0000020023",
          "M0011122"
        ],
        "pharm_class_epc": [
          "Immunoglobulin G [EPC]"
        ],
        "pharm_class_pe": [
          "Lymphocyte Function Alteration [PE]",
          "Increased T Lymphocyte Destruction [PE]"
        ],
        "pharm_class_moa": [
          "Antibody-Surface Protein Interactions [MoA]"
        ],
        "pharm_class_cs": [
          "Immunoglobulins [CS]"
        ],
        "unii": [
          "D7RD81HE4W"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
      "spl_id": "1e694a66-3d88-498c-ae79-47bc6f1c7b7d",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "19981230",
      "product_id": "58468-0080_1e694a66-3d88-498c-ae79-47bc6f1c7b7d",
      "application_number": "BLA103869",
      "brand_name_base": "Thymoglobulin",
      "pharm_class": [
        "Antibody-Surface Protein Interactions [MoA]",
        "Immunoglobulin G [EPC]",
        "Immunoglobulins [CS]",
        "Increased T Lymphocyte Destruction [PE]",
        "Lymphocyte Function Alteration [PE]"
      ]
    }
  ]
}